Spots Global Cancer Trial Database for Autophagy Markers in Endometrial Polyps

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Autophagy Markers in Endometrial Polyps

Official Title: Investigation of Autophagy Markers in Endometrial Polyps

Study ID: NCT04706000

Conditions

Endometrial Polyp

Autophagy

Interventions

Beclin 1 gene

Study Description

Brief Summary: The aim of this research is to evaluate autophagy markers in patients with endometrial polyps

Detailed Description: Endometrial polyp are benign formations that are frequently encountered in gynecology practice and have malignant potential. It may be asymptomatic in the clinic or may present with abnormal uterine bleeding. Although its pathophysiology has not been clearly revealed, there are many studies in the literature about it. However, the autophagy pathway emerges as a subject that has never been evaluated. In this study, the investigators would like to prospectively evaluate Beclin 1, LC3A / B and p62 markers in the autophagy pathway in endometrial polyp tissue samples by immunohistochemistry and reveal their importance.